Cyclerion Therapeutics, Inc.
US ˙ NasdaqCM ˙ US23255M2044

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Peter M Hecht. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Peter M Hecht har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:CYCN / Cyclerion Therapeutics, Inc. Director, 10% Owner 559.203
US:IRWD / Ironwood Pharmaceuticals, Inc. Chief Executive Officer, Director 62.500
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Peter M Hecht. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb CYCN / Cyclerion Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CYCN / Cyclerion Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2021-06-03 CYCN Hecht Peter M 823.170 3,2800 41.158 65,6000 2.699.998 11 1716 67.927.131 2.515,82
2021-05-06 CYCN Hecht Peter M 302.000 2,4300 15.100 48,6000 733.860
2021-05-05 CYCN Hecht Peter M 398.001 2,5300 19.900 50,6000 1.006.943
2021-05-04 CYCN Hecht Peter M 300.000 2,2900 15.000 45,8000 687.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CYCN / Cyclerion Therapeutics, Inc. Insider Trades
Insidersalg CYCN / Cyclerion Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CYCN / Cyclerion Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CYCN / Cyclerion Therapeutics, Inc. Insider Trades
Insiderkøb IRWD / Ironwood Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CYCN / Cyclerion Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2012-11-05 IRWD Hecht Peter M 50.000 11,6500 50.000 11,6500 582.500 130 16.2255 228.775 39,27

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

IRWD / Ironwood Pharmaceuticals, Inc. Insider Trades
Insidersalg IRWD / Ironwood Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CYCN / Cyclerion Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2017-12-07 IRWD Hecht Peter M 57.405 15,0000 57.405 15,0000 861.075 342 9.5718 -311.606 -36,19
2017-12-06 IRWD Hecht Peter M 56.000 15,2400 56.000 15,2400 853.440
2015-12-15 IRWD Hecht Peter M 73.418 11,0700 73.418 11,0700 812.737
2015-03-17 IRWD Hecht Peter M 11.903 15,7700 11.903 15,7700 187.710
2015-03-17 IRWD Hecht Peter M 113.097 15,6100 113.097 15,6100 1.765.444
2015-03-16 IRWD Hecht Peter M 75.000 15,6000 75.000 15,6000 1.170.000
2015-03-03 IRWD Hecht Peter M 6.200 15,7100 6.200 15,7100 97.402
2015-03-02 IRWD Hecht Peter M 13.908 16,0000 13.908 16,0000 222.528
2015-02-27 IRWD Hecht Peter M 20.400 16,0600 20.400 16,0600 327.624
2015-02-27 IRWD Hecht Peter M 22.934 15,3400 22.934 15,3400 351.808

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

IRWD / Ironwood Pharmaceuticals, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Peter M Hecht som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-03-27 2025-03-25 4 CYCN Cyclerion Therapeutics, Inc.
Common Stock
A - Award 181.818 559.203 48,18 2,75 500.000 1.537.808
2024-01-26 2024-01-01 4 CYCN Cyclerion Therapeutics, Inc.
Common Stock
A - Award 15.000 377.385 4,14
2023-12-04 2023-12-01 4 CYCN Cyclerion Therapeutics, Inc.
Common Stock
A - Award 15.000 362.385 4,32
2023-12-04 2023-11-30 4 CYCN Cyclerion Therapeutics, Inc.
Common Stock
A - Award 20.000 347.385 6,11
2023-05-22 2023-05-19 4 CYCN Cyclerion Therapeutics, Inc.
Common Stock
A - Award 225.000 327.385 219,76 8,68 1.953.000 2.841.702
2022-01-24 2022-01-20 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 430.000 430.000
2022-01-24 2022-01-03 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 52.950 52.950
2021-06-07 2021-06-03 4 CYCN Cyclerion Therapeutics, Inc.
Common Stock
P - Purchase 823.170 2.047.698 67,22 3,28 2.699.998 6.716.449
2021-05-10 2021-05-06 4 CYCN Cyclerion Therapeutics, Inc.
Common Stock
P - Purchase 302.000 1.224.528 32,74 2,43 733.860 2.975.603
2021-05-06 2021-05-05 4 CYCN Cyclerion Therapeutics, Inc.
Common Stock
P - Purchase 398.001 922.528 75,88 2,53 1.006.943 2.333.996
2021-05-06 2021-05-04 4 CYCN Cyclerion Therapeutics, Inc.
Common Stock
P - Purchase 300.000 524.527 133,61 2,29 687.000 1.201.167
2020-04-02 2020-03-31 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 153.846 153.846 2,65 407.692 407.692
2019-11-26 2019-11-22 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 75.000 75.000
2019-09-20 2019-04-01 4/A CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 857.830 857.830
2019-09-20 2019-04-01 4/A CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 380.330 380.330
2019-09-20 2019-04-01 4/A CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 344.777 344.777
2019-09-20 2019-04-01 4/A CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 223.893 223.893
2019-09-20 2019-04-01 4/A CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 37.972 37.972
2019-09-20 2019-04-01 4/A CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 43.679 43.679
2019-09-20 2019-04-01 4/A CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 36.088 36.088
2019-09-20 2019-04-01 4/A CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 53.083 53.083
2019-09-20 2019-04-01 4/A CYCN Cyclerion Therapeutics, Inc.
Common Stock
A - Award 221.736 221.736
2019-07-12 2019-07-10 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -2.000 0 -100,00
2019-07-12 2019-07-10 4 CYCN Cyclerion Therapeutics, Inc.
Common Stock
M - Exercise 2.000 225.192 0,90 6,04 12.080 1.360.160
2019-04-03 2019-04-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -937.500 62.500 -93,75
2019-04-03 2019-04-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -398.750 181.250 -68,75
2019-04-03 2019-04-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -332.500 427.500 -43,75
2019-04-03 2019-04-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -166.875 723.125 -18,75
2019-04-03 2019-04-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -6.771 318.229 -2,08
2019-04-03 2019-04-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -7.645 367.355 -2,04
2019-04-03 2019-04-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -7.533 292.467 -2,51
2019-04-03 2019-04-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -44.020 130.980 -25,15
2019-04-03 2019-04-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -20.000 20.000 -50,00
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 857.977 857.977
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 380.393 380.393
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 344.829 344.829
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 223.919 223.919
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 56.500 56.500
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 37.973 37.973
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 43.680 43.680
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 36.089 36.089
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 53.090 53.090
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 12.499 12.499
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 2.000 2.000
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Common Stock
A - Award 485 485
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Common Stock
A - Award 485 485
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Common Stock
A - Award 485 485
2019-04-03 2019-04-01 4 CYCN Cyclerion Therapeutics, Inc.
Common Stock
A - Award 223.192 223.192
2019-03-06 2019-03-05 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
G - Gift -2.500.000 2.217.366 -53,00
2019-01-31 2019-01-29 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 1.000.000 1.000.000
2019-01-25 2019-01-25 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -20.449 0 -100,00
2019-01-25 2019-01-25 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -29.551 20.449 -59,10
2019-01-25 2019-01-25 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
M - Exercise 20.449 4.717.366 0,44 4,89 99.996 23.067.920
2019-01-25 2019-01-25 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -29.551 4.696.917 -0,63 12,23 -361.409 57.443.295
2019-01-25 2019-01-25 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
M - Exercise 29.551 4.726.468 0,63 4,89 144.504 23.112.429
2019-01-25 2019-01-24 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -30.000 50.000 -37,50
2019-01-25 2019-01-24 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -30.000 4.696.917 -0,63 12,70 -381.000 59.650.846
2019-01-25 2019-01-24 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
M - Exercise 30.000 4.726.917 0,64 4,89 146.700 23.114.624
2019-01-25 2019-01-23 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -30.000 80.000 -27,27
2019-01-25 2019-01-23 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale X -30.000 4.696.917 -0,63 12,66 -379.800 59.462.969
2019-01-25 2019-01-23 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
M - Exercise 30.000 4.726.917 0,64 4,89 146.700 23.114.624
2019-01-03 2018-12-31 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
J - Other 40.000 40.000
2019-01-03 2018-12-31 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
J - Other -40.000 0 -100,00
2019-01-03 2018-12-31 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
J - Other 110.000 110.000
2019-01-03 2018-12-31 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
J - Other -110.000 0 -100,00
2019-01-03 2018-12-31 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
J - Other 4.696.917 4.696.917
2019-01-03 2018-12-31 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
J - Other -4.696.917 0 -100,00
2018-02-22 2018-02-21 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 580.000 580.000
2017-12-08 2017-12-07 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -57.405 0 -100,00
2017-12-08 2017-12-07 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale -57.405 4.696.917 -1,21 15,00 -861.075 70.453.755
2017-12-08 2017-12-07 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 57.405 4.754.322 1,22 3,76 215.843 17.876.251
2017-12-08 2017-12-06 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -56.000 57.405 -49,38
2017-12-08 2017-12-06 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -26.595 113.405 -19,00
2017-12-08 2017-12-06 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale -56.000 4.696.917 -1,18 15,24 -853.440 71.581.015
2017-12-08 2017-12-06 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 56.000 4.752.917 1,19 3,76 210.560 17.870.968
2017-12-08 2017-12-06 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 26.595 4.696.917 0,57 3,76 99.997 17.660.408
2017-03-01 2017-02-27 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 760.000 760.000
2017-01-13 2017-01-12 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -32.994 0 -100,00 2,94 -97.002
2017-01-13 2017-01-12 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale X -32.994 4.670.322 -0,70 15,50 -511.407 72.389.991
2017-01-13 2017-01-12 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 32.994 4.703.316 0,71 2,94 97.002 13.827.749
2017-01-13 2017-01-11 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -32.993 32.994 -50,00 2,94 -96.999 97.002
2017-01-13 2017-01-11 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale X -32.993 4.670.322 -0,70 15,84 -522.609 73.977.900
2017-01-13 2017-01-11 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 32.993 4.703.315 0,71 2,94 96.999 13.827.746
2016-03-11 2016-03-11 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy
M - Exercise -40.000 0 -100,00 1,56 -62.400
2016-03-11 2016-03-11 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale X -40.000 4.670.322 -0,85 10,66 -426.400 49.785.633
2016-03-11 2016-03-11 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 40.000 4.710.322 0,86 1,56 62.400 7.348.102
2016-03-11 2016-03-10 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -40.000 40.000 -50,00 1,56 -62.400 62.400
2016-03-11 2016-03-10 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale X -40.000 4.670.322 -0,85 10,63 -425.200 49.645.523
2016-03-11 2016-03-10 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 40.000 4.710.322 0,86 1,56 62.400 7.348.102
2016-03-11 2016-03-09 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -220.790 80.000 -73,40 1,56 -344.432 124.800
2016-03-11 2016-03-09 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale X -40.000 4.670.322 -0,85 10,87 -434.800 50.766.400
2016-03-11 2016-03-09 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 220.790 4.710.322 4,92 1,56 344.432 7.348.102
2016-03-03 2016-03-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 890.000 890.000
2015-12-15 2015-12-15 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
S - Sale -73.418 0 -100,00 11,07 -812.737
2015-12-15 2015-12-11 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -250.000 300.790 -45,39
2015-12-15 2015-12-11 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 250.000 4.489.532 5,90 1,56 390.000 7.003.670
2015-10-29 2015-10-28 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -34.013 65.987 -34,01
2015-10-29 2015-10-28 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -35.000 0 -100,00
2015-10-29 2015-10-28 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -29.102 550.790 -5,02
2015-10-29 2015-10-28 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 34.013 4.239.532 0,81 2,94 99.998 12.464.224
2015-10-29 2015-10-28 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 35.000 4.205.519 0,84 1,56 54.600 6.560.610
2015-10-29 2015-10-28 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 29.102 4.170.519 0,70 1,56 45.399 6.506.010
2015-03-18 2015-03-17 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -125.000 579.892 -17,73
2015-03-18 2015-03-17 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale -113.097 4.141.417 -2,66 15,61 -1.765.444 64.647.519
2015-03-18 2015-03-17 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale -11.903 4.254.514 -0,28 15,77 -187.710 67.093.686
2015-03-18 2015-03-17 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 125.000 4.266.417 3,02 1,56 195.000 6.655.611
2015-03-18 2015-03-16 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 565.000 565.000
2015-03-18 2015-03-16 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -75.000 704.892 -9,62
2015-03-18 2015-03-16 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale -75.000 4.141.417 -1,78 15,60 -1.170.000 64.606.105
2015-03-18 2015-03-16 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 75.000 4.216.417 1,81 1,56 117.000 6.577.611
2015-03-03 2015-03-03 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -6.200 779.892 -0,79
2015-03-03 2015-03-03 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale -6.200 4.141.417 -0,15 15,71 -97.402 65.061.661
2015-03-03 2015-03-03 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 6.200 4.147.617 0,15 1,56 9.672 6.470.283
2015-03-03 2015-03-02 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -13.908 786.092 -1,74
2015-03-03 2015-03-02 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale -13.908 4.141.417 -0,33 16,00 -222.528 66.262.672
2015-03-03 2015-03-02 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 13.908 4.155.325 0,34 1,56 21.696 6.482.307
2015-03-03 2015-02-27 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -60.000 0 -100,00
2015-03-03 2015-02-27 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -60.000 0 -100,00
2015-03-03 2015-02-27 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -90.000 0 -100,00
2015-03-03 2015-02-27 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale -22.934 4.141.417 -0,55 15,34 -351.808 63.529.337
2015-03-03 2015-02-27 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
S - Sale -20.400 4.164.351 -0,49 16,06 -327.624 66.879.477
2015-03-03 2015-02-27 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 210.000 4.184.751 5,28 0,60 126.000 2.510.851
2014-12-12 2014-10-20 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
G - Gift 1.070 4.850 28,31
2014-12-12 2014-10-20 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
G - Gift 1.070 4.850 28,31
2014-12-12 2014-10-20 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
G - Gift 1.070 4.053.019 0,03
2014-03-05 2014-03-03 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 325.000 325.000
2014-02-24 2014-02-20 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -75.000 0 -100,00
2014-02-24 2014-02-20 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -100.000 0 -100,00
2014-02-24 2014-02-20 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -50.000 0 -100,00
2014-02-24 2014-02-20 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 75.000 3.974.751 1,92 0,60 45.000 2.384.851
2014-02-24 2014-02-20 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 100.000 3.899.751 2,63 0,60 60.000 2.339.851
2014-02-24 2014-02-20 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 50.000 3.799.751 1,33 0,60 30.000 2.279.851
2013-07-08 2013-07-08 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -50.000 0 -100,00
2013-07-08 2013-07-08 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -50.000 0 -100,00
2013-07-08 2013-07-08 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 50.000 3.749.751 1,35 0,60 30.000 2.249.851
2013-07-08 2013-07-08 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 50.000 3.699.751 1,37 0,60 30.000 2.219.851
2013-04-30 2013-04-26 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
G - Gift 795 3.780 26,63
2013-04-30 2013-04-26 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
G - Gift 795 3.780 26,63
2013-04-30 2013-04-26 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
G - Gift 795 3.780 26,63
2013-03-29 2013-03-27 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
J - Other 615 73.418 0,84
2013-02-05 2013-02-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 375.000 375.000
2012-11-06 2012-11-05 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
P - Purchase 50.000 72.803 219,27 11,65 582.500 848.155
2012-08-17 2012-08-15 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
G - Gift 970 2.985 48,14
2012-08-17 2012-07-27 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
G - Gift 970 2.985 48,14
2012-08-17 2012-07-27 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class A Common Stock
G - Gift 970 2.985 48,14
2012-04-09 2012-04-05 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -100.000 0 -100,00
2012-04-09 2012-04-05 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -50.000 0 -100,00
2012-04-09 2012-04-05 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 100.000 3.649.751 2,82 0,41 41.000 1.496.398
2012-04-09 2012-04-05 4 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
M - Exercise 50.000 3.549.751 1,43 0,41 20.500 1.455.398
2012-02-03 2012-02-01 4 IRWD IRONWOOD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 300.000 300.000
2010-02-02 3 IRWD IRONWOOD PHARMACEUTICALS INC
Class B Common Stock
3.499.751
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)